Skip to content

Green Coffee Extract and Metabolic Syndrome

Effects of Green Coffee Extract Supplementation on Anthropometric Measurements, Glycemic Control, Blood Pressure, Lipid Profile

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02764957
Enrollment
43
Registered
2016-05-06
Start date
2016-12-01
Completion date
2017-04-21
Last updated
2017-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Brief summary

Metabolic syndrome (Mets) is an assemblage of risk factors which can increase the risk of developing type 2 diabetes mellitus and cardiovascular disease. Green coffee extract (GCE) is derived from unroasted coffee beans and has substantial amounts of polyphenols primarily chlorogenic acids (CGA). It has been shown that GCE and CGA can exert a positive influence over Mets components including blood pressure, blood glucose, inflammation, oxidative stress, insulin resistance and blood lipids. Up to our knowledge no study has been conducted on humans in the field of GCA influences on Mets patients. Therefore, this study is planned to evaluate GCA supplementation effects on anthropometric measurements, glycemic control, blood pressure, lipid profile in patients with metabolic syndrome.

Interventions

DIETARY_SUPPLEMENTgreen coffee extract
DIETARY_SUPPLEMENTplacebo

Sponsors

National Nutrition and Food Technology Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Waist circumference\>102 cm in men and \>88 cm in women * Fasting blood glucose\>100 mg/dL (5.6 mmol /L) * Systolic blood pressure\>130 mmHg or diastolic blood pressure\>85mmHg * Triglycerides\> 150 mg/dL (1.7 mmol/L)

Exclusion criteria

* Insulin administration * Pregnancy and breastfeeding * regular consumption of coffee and green tea

Design outcomes

Primary

MeasureTime frame
fasting blood glucose8 weeks

Secondary

MeasureTime frame
HOMA-IR8 weeks
blood pressure8 weeks
insulin8 weeks
hemoglubin A1c8 weeks
triglyceride8 weeks

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026